🇺🇸 FDA

Intelligence · Drug directory

Withdrawn Drug Applications

Drugs with withdrawn or discontinued regulatory applications in the US or EU — useful for competitive and label-history research.

Quick answer

Withdrawn applications: NovaPharmaNews tracks 229 pharmaceutical drugs in this segment. Drugs with withdrawn or discontinued regulatory applications in the US or EU — useful for competitive and label-history research.

229 drugs · Withdrawn · by data quality · Page 8 of 10

  1. meningococcal groups a, c, w, y conjugate and group b vaccine (recombinant, adsorbed)

    PENBRAYA

    EMA: withdrawn

    J07AH11

  2. molnupiravir

    LAGEVRIO Merck KGaA, Darmstadt, Germany

    EMA: application withdrawn · TGA: approved · PMDA: approved

    J05A

  3. moxetumomab pasudotox

    LUMOXITI

    EMA: withdrawn

    L01X

  4. naproxcinod

    BEPRANA

    EMA: application withdrawn

  5. nelfinavir

    VIRACEPT

    EMA: withdrawn

    J05AE04

  6. nimotuzumab

    THERALOC

    EMA: application withdrawn · NMPA: clinical trials

  7. nomegestrol acetate

    IOA

    EMA: withdrawn

    G03AA14

  8. omecamtiv mecarbil

    KINHARTO

    EMA: application withdrawn

    C01CX10

  9. oportuzumab monatox

    OPORTUZUMAB MONATOX DLRC PHARMA SERVICES

    EMA: application withdrawn

    L01FX06

  10. pancreas powder

    ENZEPI

    EMA: withdrawn

    A09AA02

  11. pandemic influenza vaccine (h1n1) (split virion, inactivated, adjuvanted)

    HUMENZA

    EMA: withdrawn

    J07BB02

  12. pandemic influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)

    AREPANRIX

    EMA: withdrawn

    J07BB02

  13. pandemic influenza vaccine (h5n1) (whole virion, inactivated, prepared in cell culture)

    PANDEMIC INFLUENZA VACCINE H5N1 BAXTER AG

    EMA: withdrawn

    J07BB01

  14. para-aminosalicylic acid

    GRANUPAS (PREVIOUSLY PARA-AMINOSALICYLIC ACID LUCANE)

    EMA: withdrawn

    J04AA01

  15. parathyroid hormone (rdna)

    PREOTACT

    EMA: withdrawn

    H05AA03

  16. parsaclisib

    PARSACLISIB INCYTE BIOSCIENCES DISTRIBUTION B.V.

    EMA: application withdrawn

    L01EM04

  17. pegaptanib

    MACUGEN

    EMA: withdrawn

    S01LA03

  18. peginterferon alfa-2b

    CYLATRON

    FDA: approved · EMA: withdrawn

    L03AB10

  19. perflubutane

    IMAGIFY

    EMA: application withdrawn

    V08D

  20. plazomicin (sulfate)

    ZEMDRI

    EMA: application withdrawn

  21. plitidepsin

    APLIDIN

    EMA: application withdrawn

    L01

  22. pneumococcal saccharide conjugated vaccine, adsorbed

    PREVENAR

    EMA: withdrawn

    J07AL02

  23. prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted)

    PREPANDRIX

    EMA: withdrawn

    J07BB02

  24. prepandemic influenza vaccine (h5n1) (whole virion, inactivated,prepared in cell culture)

    VEPACEL

    EMA: withdrawn

    J07BB01

Frequently asked questions

How many withdrawn drugs are listed?

229 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.